Search Ontology:
ChEBI
[19-acetyloxy-2-hydroxy-7-(2-hydroxypropan-2-yl)-4,12,17,18,20-pentamethyl-23-oxo-8,13,16-trioxahexacyclo[12.9.0.03,12.04,9.015,18.015,21]tricosa-1(14),21-dien-5-yl] acetate
- Term ID
- CHEBI:181313
- Synonyms
-
- [19-acetyloxy-2-hydroxy-7-(2-hydroxypropan-2-yl)-4,12,17,18,20-pentamethyl-23-oxo-8,13,16-trioxahexacyclo[12.9.0.03,12.04,9.015,18.015,21]tricosa-1(14),21-dien-5-yl] acetate
- Definition
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from [19-acetyloxy-2-hydroxy-7-(2-hydroxypropan-2-yl)-4,12,17,18,20-pentamethyl-23-oxo-8,13,16-trioxahexacyclo[12.9.0.03,12.04,9.015,18.015,21]tricosa-1(14),21-dien-5-yl] acetate
Phenotype where environments contain [19-acetyloxy-2-hydroxy-7-(2-hydroxypropan-2-yl)-4,12,17,18,20-pentamethyl-23-oxo-8,13,16-trioxahexacyclo[12.9.0.03,12.04,9.015,18.015,21]tricosa-1(14),21-dien-5-yl] acetate
Phenotype modified by environments containing [19-acetyloxy-2-hydroxy-7-(2-hydroxypropan-2-yl)-4,12,17,18,20-pentamethyl-23-oxo-8,13,16-trioxahexacyclo[12.9.0.03,12.04,9.015,18.015,21]tricosa-1(14),21-dien-5-yl] acetate
Human Disease Model